These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A benefit-risk assessment of class III antiarrhythmic agents. Brendorp B, Pedersen O, Torp-Pedersen C, Sahebzadah N, Køber L. Drug Saf; 2002 Dec; 25(12):847-65. PubMed ID: 12241126 [Abstract] [Full Text] [Related]